MintNeuro Raises £1m to Revolutionize Neural Implants

MintNeuro, an Imperial College London spinout, has secured £1m in funding to advance its innovative semiconductor technology for neural implants. The company aims to address inefficiencies in current treatments for neurological disorders by making implants smaller, more efficient, and scalable. Having already garnered over £14m in R&D grants, MintNeuro's technology is poised to transform neurological care. The recent funding round, led by Empirical Ventures with contributions from Parkwalk Advisors and other investors, will accelerate MintNeuro's development and allow for team expansion. Strategic partnerships, including projects with Imperial College London and Amber Therapeutics, further enhance MintNeuro's position in the medtech landscape. The company's work is geared toward introducing safer, more effective neural implants for various conditions, potentially impacting millions of patients worldwide.